摘要
Abstract
Objective To investigate the clinical efficacy of metformin and pioglitazone in treatment of type 2 diabetes. Methods 70 cases type 2 diabetes, of which 35 patients were treated with metformin pioglitazone treatment, the establishment of the observation group, another 35 cases of type 2 diabetic patients were treated with metforminas as the control group, after treatment 6 months, fasting blood glucose (FBG), 2h postprandial blood glucose (PBG) and glycosylated hemoglobin (HbA1C) changes and adverse reactions were compared between two groups. Results After treatment, the total effective rate of observation group was 94.3%, was significantly higher than the control group 77.1%(P < 0.05). The FBG, 2h PBG, HbA1C of observation group and control group treated 6 months was significantly lower than before treatment, and the observation group was significantly lower than the control group,the difference was significant (P < 0.05). Conclusion Metformin and pioglitazone can significantly improve blood sugar and glycosylated hemoglobin levels in type 2 diabetes, the efficacy is good, should be promoted and applied.关键词
2型糖尿病/二甲双胍/吡格列酮Key words
Type 2 diabetes/Metformin/Pioglitazone分类
医药卫生
